Aditxt Inc

ADTX10 Dec 2024
Healthcare
$0.34
+0.01 (+0.57%)
Lowest Today
$0.34
Highest Today
$0.37
Today’s Open
$0.34
Prev. Close
$0.35
52 Week High
$380
52 Week Low
$0.31
To Invest in Aditxt Inc

Aditxt Inc

Healthcare
ADTX10 Dec 2024
+0.01 (+0.57%)
1M
3M
6M
1Y
5Y
Low
$0.34
Day’s Range
High
$0.36
0.34
52 Week Low
$0.31
52-Week Range
52 Week High
$380
0.31
1 Day
-
1 Week
+0.41%
1 month return
-3.07%
3 month return
-24.06%
6 month return
-81.02%
1 Year return
-90.46%
3 Years return
-99.97%
5 Years return
-
10 Years return
-
Institutional Holdings
UBS Group AG
0.02
Two Sigma Investments LLC
0.01
StoneX Group Inc
0
Geode Capital Management, LLC
0
Fidelity Extended Market Index
0
Tower Research Capital LLC
0
NT Ext Equity Mkt Idx Fd - L
0

Market Status

Fundamentals
Market Cap
4.97 mln
PB Ratio
1.05
PE Ratio
0
Enterprise Value
14.75 mln
Total Assets
44.58 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Organisation
Aditxt Inc
Employees
47
Industry
Biotechnology
CEO
Mr. Amro A. Albanna
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step